Literature DB >> 23684312

Quantitative phosphoproteomics reveals extensive cellular reprogramming during HIV-1 entry.

Jason A Wojcechowskyj1, Chuka A Didigu1, Jessica Y Lee2, Nicholas F Parrish3, Rohini Sinha4, Beatrice H Hahn3, Frederic D Bushman5, Shane T Jensen6, Steven H Seeholzer2, Robert W Doms7.   

Abstract

Receptor engagement by HIV-1 during host cell entry activates signaling pathways that can reprogram the cell for optimal viral replication. To obtain a global view of the signaling events induced during HIV-1 entry, we conducted a quantitative phosphoproteomics screen of primary human CD4(+) T cells after infection with an HIV-1 strain that engages the receptors CD4 and CXCR4. We quantified 1,757 phosphorylation sites with high stringency. The abundance of 239 phosphorylation sites from 175 genes, including several proteins in pathways known to be impacted by HIV-receptor binding, changed significantly within a minute after HIV-1 exposure. Several previously uncharacterized HIV-1 host factors were also identified and confirmed through RNAi depletion studies. Surprisingly, five serine/arginine-rich (SR) proteins involved in messenger RNA splicing, including the splicing factor SRm300 (SRRM2), were differentially phosophorylated. Mechanistic studies with SRRM2 suggest that HIV-1 modulates host cell alternative splicing machinery during entry in order to facilitate virus replication and release.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23684312      PMCID: PMC4104530          DOI: 10.1016/j.chom.2013.04.011

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  51 in total

1.  Alternative splicing networks regulated by signaling in human T cells.

Authors:  Nicole M Martinez; Qun Pan; Brian S Cole; Christopher A Yarosh; Grace A Babcock; Florian Heyd; William Zhu; Sandya Ajith; Benjamin J Blencowe; Kristen W Lynch
Journal:  RNA       Date:  2012-03-27       Impact factor: 4.942

2.  HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells.

Authors:  Sonja I Gringhuis; Michiel van der Vlist; Linda M van den Berg; Jeroen den Dunnen; Manja Litjens; Teunis B H Geijtenbeek
Journal:  Nat Immunol       Date:  2010-04-04       Impact factor: 25.606

3.  GPS 2.1: enhanced prediction of kinase-specific phosphorylation sites with an algorithm of motif length selection.

Authors:  Yu Xue; Zexian Liu; Jun Cao; Qian Ma; Xinjiao Gao; Qingqi Wang; Changjiang Jin; Yanhong Zhou; Longping Wen; Jian Ren
Journal:  Protein Eng Des Sel       Date:  2010-11-08       Impact factor: 1.650

Review 4.  Signaling through the P38 and ERK pathways: a common link between HIV replication and the immune response.

Authors:  Robert L Furler; Christel H Uittenbogaart
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

Review 5.  Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.

Authors:  Marie Cargnello; Philippe P Roux
Journal:  Microbiol Mol Biol Rev       Date:  2011-03       Impact factor: 11.056

Review 6.  Cyclic AMP-mediated immune regulation--overview of mechanisms of action in T cells.

Authors:  Randi Mosenden; Kjetil Taskén
Journal:  Cell Signal       Date:  2010-12-02       Impact factor: 4.315

7.  Quantitative phosphoproteomic analysis reveals a role for serine and threonine kinases in the cytoskeletal reorganization in early T cell receptor activation in human primary T cells.

Authors:  Patricia Ruperez; Ana Gago-Martinez; A L Burlingame; Juan A Oses-Prieto
Journal:  Mol Cell Proteomics       Date:  2012-04-12       Impact factor: 5.911

8.  Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling.

Authors:  Jason A Wojcechowskyj; Jessica Y Lee; Steven H Seeholzer; Robert W Doms
Journal:  PLoS One       Date:  2011-09-20       Impact factor: 3.240

9.  HIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA).

Authors:  Catarina E Hioe; Michael Tuen; Gaia Vasiliver-Shamis; Yelina Alvarez; Kathleen C Prins; Sagarika Banerjee; Arthur Nádas; Michael W Cho; Michael L Dustin; Scott C Kachlany
Journal:  PLoS One       Date:  2011-08-05       Impact factor: 3.240

10.  Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7.

Authors:  Nicholas F Parrish; Craig B Wilen; Lauren B Banks; Shilpa S Iyer; Jennifer M Pfaff; Jesus F Salazar-Gonzalez; Maria G Salazar; Julie M Decker; Erica H Parrish; Anna Berg; Jennifer Hopper; Bhavna Hora; Amit Kumar; Tatenda Mahlokozera; Sally Yuan; Charl Coleman; Marion Vermeulen; Haitao Ding; Christina Ochsenbauer; John C Tilton; Sallie R Permar; John C Kappes; Michael R Betts; Michael P Busch; Feng Gao; David Montefiori; Barton F Haynes; George M Shaw; Beatrice H Hahn; Robert W Doms
Journal:  PLoS Pathog       Date:  2012-05-31       Impact factor: 6.823

View more
  41 in total

Review 1.  Comparative mapping of host-pathogen protein-protein interactions.

Authors:  Priya S Shah; Jason A Wojcechowskyj; Manon Eckhardt; Nevan J Krogan
Journal:  Curr Opin Microbiol       Date:  2015-08-10       Impact factor: 7.934

2.  Global Reprogramming of Host Kinase Signaling in Response to Fungal Infection.

Authors:  Aseem Pandey; Sheng Li Ding; Qing-Ming Qin; Rahul Gupta; Gabriel Gomez; Furong Lin; Xuehuan Feng; Luciana Fachini da Costa; Sankar P Chaki; Madhu Katepalli; Elizabeth D Case; Erin J van Schaik; Tabasum Sidiq; Omar Khalaf; Angela Arenas; Koichi S Kobayashi; James E Samuel; Gonzalo M Rivera; Robert C Alaniz; Sing-Hoi Sze; Xiaoning Qian; William J Brown; Allison Rice-Ficht; William K Russell; Thomas A Ficht; Paul de Figueiredo
Journal:  Cell Host Microbe       Date:  2017-05-10       Impact factor: 21.023

Review 3.  Lassa Virus Cell Entry Reveals New Aspects of Virus-Host Cell Interaction.

Authors:  Giulia Torriani; Clara Galan-Navarro; Stefan Kunz
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

4.  Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human Macrophages.

Authors:  Sandra Söderholm; Denis E Kainov; Tiina Öhman; Oxana V Denisova; Bert Schepens; Evgeny Kulesskiy; Susumu Y Imanishi; Garry Corthals; Petteri Hintsanen; Tero Aittokallio; Xavier Saelens; Sampsa Matikainen; Tuula A Nyman
Journal:  Mol Cell Proteomics       Date:  2016-08-02       Impact factor: 5.911

Review 5.  Proteomics in the investigation of HIV-1 interactions with host proteins.

Authors:  Ming Li
Journal:  Proteomics Clin Appl       Date:  2015-01-19       Impact factor: 3.494

6.  Quantitative Temporal Viromics of an Inducible HIV-1 Model Yields Insight to Global Host Targets and Phospho-Dynamics Associated with Protein Vpr.

Authors:  John D Lapek; Mary K Lewinski; Jacob M Wozniak; John Guatelli; David J Gonzalez
Journal:  Mol Cell Proteomics       Date:  2017-06-12       Impact factor: 5.911

7.  Mass spectrometry-based proteomic approaches for discovery of HIV-host interactions.

Authors:  Yang Luo; Mark A Muesing
Journal:  Future Virol       Date:  2014       Impact factor: 1.831

8.  Phosphoproteome Analysis of Cells Infected with Adapted and Nonadapted Influenza A Virus Reveals Novel Pro- and Antiviral Signaling Networks.

Authors:  Axel Weber; Sharmistha Dam; Vera V Saul; Irina Kuznetsova; Christin Müller; Karin Fritz-Wolf; Katja Becker; Uwe Linne; Hongbo Gu; Matthew P Stokes; Stephan Pleschka; Michael Kracht; M Lienhard Schmitz
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

9.  Improving data quality and preserving HCD-generated reporter ions with EThcD for isobaric tag-based quantitative proteomics and proteome-wide PTM studies.

Authors:  Qing Yu; Xudong Shi; Yu Feng; K Craig Kent; Lingjun Li
Journal:  Anal Chim Acta       Date:  2017-03-16       Impact factor: 6.558

10.  Epidermal Growth Factor Receptor and Abl2 Kinase Regulate Distinct Steps of Human Papillomavirus 16 Endocytosis.

Authors:  Carina Bannach; Pia Brinkert; Lena Kühling; Lilo Greune; M Alexander Schmidt; Mario Schelhaas
Journal:  J Virol       Date:  2020-05-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.